Washington: In a bold and unexpected move, U.S. President Donald Trump announced that effective October 1, 2025, all branded and patented pharmaceutical imports will face a 100 percent tariff, a decision that has sent shockwaves through the global pharmaceutical market. The new policy is aimed at encouraging domestic manufacturing, with exemptions granted only to companies actively constructing production facilities within the United States.

The announcement, made via Trump’s social media platforms and official statements, cited national security and economic revitalization as key drivers for the measure. It also forms part of a broader protectionist agenda, which includes steep tariffs on other imported goods such as kitchen cabinets, upholstered furniture, and heavy trucks. According

See Full Page